Clariant Expands Early Phase Capability

摘要

Clariant says it has set up a technology center at Frankfurt that offers R&D, process development, and small-scale production for non-cGMP early-stage pharmaceutical commercialization. The facility houses more than 50 research and production staff, focusing on technology and process development and small-scale manufacturing for Phase I and II clinical trial requirements, the company says.